Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae

Respirology

Volumn 14, Issue 8, 2009, Pages 1206-1208

  Isozumi, Rie ^a   Yoshimine, Hiroyuki ^a   Morozumi, Miyuki ^b   Ubukata, Kimiko ^b   Ariyoshi, Koya ^c  

^a Inoue Hospital   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

23S rRNA mutation; Macrolide resistance; Mycoplasma pneumoniae; Pneumonia

Indexed keywords

ADENINE; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; GUANINE; LEVOFLOXACIN; MACROLIDE; PAZUFLOXACIN; SULTAMICILLIN; TELITHROMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; FEBRILE BONE MARROW APLASIA; FEMALE; GENE MUTATION; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; THROAT CULTURE;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MYCOPLASMA PNEUMONIAE; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; TREATMENT OUTCOME;

EID: 70350442748     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01619.x     Document Type: Article

References (13)

1. Morozumi M, Nakayama E, Iwata S, Aoki Y, Hasagawa K et al. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J. Clin. Microbiol. 2006 44 : 1440 1446.
2. Morozumi M, Hasegawa K, Kobayashi R, Inoue N, Iwata S et al. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation. Antimicrob. Agents Chemother. 2005 49 : 2302 2306.
3. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 1998 114 : 1588 1593.
4. McIntosh K. Community-acquired pneumonia in children. N. Engl. J. Med. 2002 346 : 429 437.
5. Miyashita N, Matsushima T, Oka M, Japanese Respiratory Society. The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations. Intern. Med. 2006 45 : 419 428.
6. Lucier TS, Heitzman K, Liu SK, Hu PC. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 1995 39 : 2770 2773.
7. Morozumi M, Iwata S, Hasegawa K, Chiba N, Takayanagi R et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia. Antimicrob. Agents Chemother. 2008 52 : 348 350.
8. Inour M, Kohno S, Kaku M, Yamaguchi K, Igari J et al. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. Int. J. Infect. Dis. 2005 9 : 27 36.
9. Hsieh SC, Kuo YT, Chern MS, Chen CY, Chan WP et al. Mycoplasma pneumonia: clinical and radiographic features in 39 children. Pediatr. Int. 2007 49 : 363 367.
10. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 2006 50 : 709 712.
11. Janahi IA, Abdulwahab A, Elshafie Sittana S, Bush A. Rapidly progressive lung disease in a patient with cystic fibrosis on long-term azithromycin: possible role of mycoplasma infection. J. Cyst. Fibros. 2005 4 : 71 3.
12. Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J. Clin. Microbiol. 2007 45 : 3534 3539.
13. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am. J. Respir. Crit. Care Med. 1998 157 : 1829 1832.